BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18495769)

  • 1. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
    Bailey JR; O'Connell K; Yang HC; Han Y; Xu J; Jilek B; Williams TM; Ray SC; Siliciano RF; Blankson JN
    J Virol; 2008 Aug; 82(15):7395-410. PubMed ID: 18495769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors.
    Bailey JR; Brennan TP; O'Connell KA; Siliciano RF; Blankson JN
    J Virol; 2009 Jan; 83(1):88-97. PubMed ID: 18945771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
    Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
    J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.
    Pohlmeyer CW; Buckheit RW; Siliciano RF; Blankson JN
    Retrovirology; 2013 Dec; 10():152. PubMed ID: 24330837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
    Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
    J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.
    Gijsbers EF; Feenstra KA; van Nuenen AC; Navis M; Heringa J; Schuitemaker H; Kootstra NA
    PLoS One; 2013; 8(12):e81235. PubMed ID: 24339913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged control of an HIV type 1 escape variant following treatment interruption in an HLA-B*27-positive patient.
    O'Connell KA; Pelz RK; Dinoso JB; Dunlop E; Paik-Tesch J; Williams TM; Blankson JN
    AIDS Res Hum Retroviruses; 2010 Dec; 26(12):1307-11. PubMed ID: 20854198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.
    Schneidewind A; Brockman MA; Yang R; Adam RI; Li B; Le Gall S; Rinaldo CR; Craggs SL; Allgaier RL; Power KA; Kuntzen T; Tung CS; LaBute MX; Mueller SM; Harrer T; McMichael AJ; Goulder PJ; Aiken C; Brander C; Kelleher AD; Allen TM
    J Virol; 2007 Nov; 81(22):12382-93. PubMed ID: 17804494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein.
    Prado JG; Honeyborne I; Brierley I; Puertas MC; Martinez-Picado J; Goulder PJ
    J Virol; 2009 Jan; 83(2):1018-25. PubMed ID: 18945768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation.
    Liu D; Zuo T; Hora B; Song H; Kong W; Yu X; Goonetilleke N; Bhattacharya T; Perelson AS; Haynes BF; McMichael AJ; Gao F
    Retrovirology; 2014 Nov; 11():101. PubMed ID: 25407514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
    Wright JK; Naidoo VL; Brumme ZL; Prince JL; Claiborne DT; Goulder PJ; Brockman MA; Hunter E; Ndung'u T
    J Virol; 2012 Mar; 86(6):3193-9. PubMed ID: 22238317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.
    Buckheit RW; Allen TG; Alme A; Salgado M; O'Connell KA; Huculak S; Falade-Nwulia O; Williams TM; Gallant JE; Siliciano RF; Blankson JN
    Nat Commun; 2012 Mar; 3():716. PubMed ID: 22395607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral suppression of multiple escape mutants by de novo CD8(+) T cell responses in a human immunodeficiency virus-1 infected elite suppressor.
    O'Connell KA; Hegarty RW; Siliciano RF; Blankson JN
    Retrovirology; 2011 Aug; 8():63. PubMed ID: 21812985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.